Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries.
Inotiv stock last closed at $4.45, down 4.3% from the previous day, and has decreased 80.74% in one year. It has underperformed other stocks in the Diagnostics & Research industry by 0.66 percentage points. Inotiv stock is currently +22.09% from its 52-week low of $3.65, and -83.65% from its 52-week high of $27.22.
As of Mar 20, 2023, there are 25.63M shares of NOTV outstanding. The market capitalization of NOTV is $114.06M. In the last 24 hours, 586,877 NOTV shares were traded.
How to Buy Inotiv Stock
Not sure how to invest in Inotiv stock? Here's how.
Figure out where to buy Inotiv stock: You need to pick an online brokerage, but don't worry - we've researched dozens of stock brokerages and apps to help you figure out where to buy Inotiv stock.
Create a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
Put funds into your investment account: Pick your method of payment and add your information.
Research Inotiv stock: The Inotiv ticker symbol is NOTV. Is Inotiv stock a good investment? Should you buy shares of NOTV? How do NOTV's underlying business fundamentals look? Do top analysts think Inotiv is a good buy? Why has NOTV's stock price moved recently? (Hint: Our stock market analysis website can help you understand if NOTV is a good stock to buy).
Make your NOTV trade: Decide if you will purchase NOTV shares at the current market price or use a limit order to buy NOTV shares at a specific price.
Keep an eye on your investment in NOTV: Create a watchlist to monitor your new investment in Inotiv stock.
Step 1: Figure out where to buy Inotiv stock
You will need an online brokerage account to access the NASDAQ market and buy NOTV stock.
A brokerage account is an investment account that allows you to buy and sell a variety of financial instruments, such as stocks, bonds, mutual funds, and ETFs.
Our favorite brokerage: eToro
We believe that eToro is the best stock brokerage. eToro gives you:
You can invest in stocks with zero commissions: Invest without commissions.
Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
Access to global markets: From Tech to Real Estate, New York to Shanghai — you can fill your portfolio with stocks from the globe's top stock exchanges.
Social investing: eToro boasts a community of more than 20 million users globally. Talk to, learn from, and copy the crypto trades of other investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by signing up for an account with eToro now.
After you have decided on the best place to buy Inotiv stock, it's absolutely critical to evaluate their stock before you buy, so you can understand the risk and upside.
Inotiv Numbers
NOTV Price
$4.45
1w %
-5.12%
1y %
-80.74%
5y %
174.69%
P/E
-0.32x
P/B
0.41x
P/S
0.19x
PEG
N/A
Revenue
$586.20M
Earnings
-$341.29M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$114.06M
Next Earnings
May 10, 2023
Next Dividend
N/A
NOTV Due Diligence Checks
WallStreetZen was created to help everyday investors do more in-depth fundamental analysis in less time.
There are more short-term assets than short-term liabilities on the NOTV balance sheet.
Failed Health Checks:
There are more long-term liabilities than short-term assets on the NOTV balance sheet.
NOTV has cash burn of 50281000. It does not have sufficient cash and short-term investments to cover this.
NOTV profit margin has gone down from -46% to -58.2% in the past year.
Total NOTV debt is higher than 5 years ago, relative to shareholder equity.
NOTV has a relatively high debt to equity ratio of 2.11.
NOTV has $20.82M in cash and short term investments. This is not enough to cover its annual cash burn of $50.28M.
Do analysts think it's a good time to buy NOTV stock
Out of 2 Wall Street analysts who research NOTV, the consensus analyst rating on NOTV is a Buy
It's important to note that analyst forecasts are not recommendations, nor are they financial advice.
Most Recent NOTV Analyst Ratings
David Windley, a top 4% analyst from Jefferies downgrades NOTV to a hold rating and lowers their NOTV price target from $10.00 to $8.00, on Jan 19, 2023.
Frank Takkinen, a bottom 1% analyst from Lake Street upgrades NOTV to a strong buy rating and raises their NOTV price target from $4.00 to $10.00, on Jan 11, 2023.
Last year, NOTV revenue was $586.20M. During the last 5 year, NOTV's revenue has increased by 90.37% per year. This was faster than the Diagnostics & Research industry average of 16.31%.
No, Inotiv doesn't provide an income stream by paying out dividends.
What others are saying about NOTV
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other community members have to say.
Step 5: Make your NOTV trade
There are two primary options:
Market order: A market order is an order to buy or sell a stock at the best price on the market. Market orders are mostly fine for most investors.
Limit order: A limit order lets you buy or sell a stock at a specific price (or better). If you want to make sure you're buying or selling at a particular dollar amount limit, use a limit order.
Press the Open button and your broker will execute your order.
If you require additional help investing in stocks on eToro, watch the how to video below:
As of Mar 20, 2023, it costs $4.45 to buy one share of Inotiv stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $2, you can buy 0.449 shares of NOTV.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.